Labyrinthin Peptide Vaccine LabVax 3(22)-23

**Semantic type:** Amino Acid, Peptide, or Protein|Immunologic Factor|Pharmacologic Substance

**Definition:** A synthetic peptide vaccine composed of four synthetic peptide epitopes of the tumor-associated antigen (TAA) labyrinthin, with potential immunomodulating and antineoplastic activities. Upon vaccination with labyrinthin peptide vaccine LabVax 3(22)-23, the labyrinthin peptides may stimulate the immune system to mount B-cell and cytotoxic T-lymphocyte (CTL) responses against labryrinthin-expressing tumor cells. Labyrinthin is expressed on the surface of essentially all adenocarcinomas, but is not expressed in normal, healthy cells.

**Synonyms:** - LabVax - LabVax 3(22)-23 - Labyrinthin-targeting Peptide Vaccine LabVax 3(22)-23 - Peptide Vaccine LabVax 3(22)-23